Cargando…
Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer
BACKGROUND: Mps one binder kinase activator 1 (MOB1) is a core component of the Hippo signaling pathway and has been implicated as a tumor suppressor. Here, we evaluated the possible relationship of MOB1 expression in non‐small cell lung cancer (NSCLC) to prognosis. METHODS: We retrospectively analy...
Autores principales: | Ando, Nobuhisa, Tanaka, Kentaro, Otsubo, Kohei, Toyokawa, Gouji, Ikematsu, Yuki, Ide, Maako, Yoneshima, Yasuto, Iwama, Eiji, Inoue, Hiroyuki, Ijichi, Kayo, Tagawa, Tetsuzo, Nakanishi, Yoichi, Okamoto, Isamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529568/ https://www.ncbi.nlm.nih.gov/pubmed/32841529 http://dx.doi.org/10.1111/1759-7714.13608 |
Ejemplares similares
-
Paired genetic analysis by next‐generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis
por: Otsubo, Kohei, et al.
Publicado: (2020) -
(18)F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer
por: Takada, Kazuki, et al.
Publicado: (2019) -
IgG4-Related Lung Disease Exhibiting the Invasion into the Diaphragm: A Case Report
por: Ono, Yuki, et al.
Publicado: (2020) -
MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer
por: Gundogdu, Ramazan, et al.
Publicado: (2019) -
Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade
por: Tanaka, Kentaro, et al.
Publicado: (2018)